Trial Profile
Postoperative tiotropium bromide and salmeterol, versus no bronchodilator therapy, in patients with chronic obstructive pulmonary disease and lung cancer undergoing lobectomy.
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 18 Dec 2007
Price :
$35
*
At a glance
- Drugs Salmeterol (Primary) ; Tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 18 Dec 2007 New trial record.